in the 3Q12 results released on 9 nov, these were the next events expected. which one might it be???
Upcoming milestones:
• Announcement of EU site selection for post-marketing trial for the C-Pulse System expected to commence in the fourth quarter of 2012
• Unconditional IDE approval from the FDA expected in the fourth quarter of 2012
• Initiation of pivotal trial planned for the fourth quarter of 2012
- Forums
- ASX - By Stock
- trading halt
in the 3Q12 results released on 9 nov, these were the next...
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online